A complete timeline of what’s going on with the AstraZeneca Covid vaccine

‘AstraZeneca, the British-Swedish pharmaceutical giant based in Cambridge, England, has little track record in vaccines, but it managed to score a coup by partnering with scientists at the University of Oxford’s Jenner Institute to help bring its COVID-19 vaccine to market. The company penned deals to deliver billions of vaccines around the world.

‘Yet, of the major vaccine in the global market, AstraZeneca's has had the roughest ride. Between halted trials, confusing data, and communication mishaps, the company is now facing suspended vaccinations and a decrease in trust in its vaccine.’

Read here (Fortune, Apr 2, 2021)

Covid hollows out the middle class everywhere, pushing millions into poverty, new research finds

‘The COVID-19 pandemic has eroded living standards around the globe, shrinking the global middle class and swelling the number of people in poverty amid a historic collapse in economic activity.

‘Analysis from Pew Research Center found that the global economic recession brought on by the pandemic shrank the worldwide middle class by 54 million, and increased the number of people in poverty by 131 million.

‘The middle-class falloff was most evident in South Asia, East Asia, and the Pacific, where the expansion seen over previous years came to a virtual halt. But it could have been worse: “The erosion in the middle class might have been deeper if not for the fact that China—which is home to more than one-third of the global middle class—evaded an economic contraction, even though growth there was slower than anticipated,” the Pew study said.’

Read here (Fortune, Mar 18, 2021)

World’s vaccine testing ground deems Chinese Covid candidate ‘the safest, most promising’

‘Brazil is one of the world’s top COVID-19 vaccine testing grounds. Now officials there say that CoronaVac, the experimental COVID-19 vaccine from Chinese developer Sinovac, is the safest of the coronavirus immunizations evaluated in the country so far.

“The first results of the clinical study conducted in Brazil prove that among all the vaccines tested in the country, CoronaVac is the safest, the one with the best and most promising rates,” São Paulo Gov. João Doria told reporters in Brazil on Monday.’

Read here (Fortune, Oct 20, 2020)

‘The whole world is coming together’: How the race for a COVID vaccine is revolutionizing Big Pharma

‘There are few people on earth who better understand the power of vaccines—or who know more about the challenge of developing, vetting, and distributing them around the world—than [Seth] Berkley. The physician and epidemiologist presides over GAVI, the Vaccine Alliance, which over the past 20 years has immunized nearly 800 million children against a host of deadly pathogens, saving millions of lives. 

‘Before becoming GAVI’s CEO in 2011, Berkley founded and led the International AIDS Vaccine Initiative—which itself was a long lesson in both perseverance and keeping one’s expectations in check. There is, after all, no vaccine yet for HIV, the virus that causes AIDS, despite nearly four decades of global endeavor. Nor is there one for SARS or MERS, those two other deadly coronaviruses that have emerged in recent years—nor for Lyme disease, West Nile virus, Zika, or the common cold.

‘Yet in one striking way, the swarm of initiatives to develop vaccines against COVID is unique, says Berkley. That is in the readiness of pharmaceutical companies to stand together in one very important common cause: ensuring that when vaccines are ready, they are available to the whole world at the same time.’

Read here (Fortune, Sept 21, 2020)

South Korea amassed the world’s most comprehensive coronavirus data. What it’s taught us so far

“South Korea’s data is valuable, in part, because it provides a stark warning to the world that there are likely far more young and asymptomatic carriers of the coronavirus than are currently being tallied, especially in countries like the U.S. that are suffering from ongoing testing shortages.

“As of March 14, South Korea reported that nearly 30% of its confirmed coronavirus cases were in patients ages 20 to 29. In Italy, by comparison, 3.7% of coronavirus patients fell into that age range, according to a report from Andreas Backhaus, a research fellow at the Centre for European Policy Studies.”

Read here (Fortune, March 19, 2020)